Publications by authors named "Adam Goszczynski"
Front Pharmacol
March 2023
Article Synopsis
- The text discusses a new approach to treating advanced renal cancer by combining immunotherapy and targeted therapy, particularly focusing on cabozantinib + nivolumab.
- The review compares this combination with other therapies recommended in current guidelines, looking at their effectiveness in clinical trials for metastatic clear-cell renal cell carcinoma (RCC).
- A network meta-analysis (NMA) indicated that cabozantinib + nivolumab outperformed other treatments like axitinib + pembrolizumab and nivolumab + ipilimumab in terms of overall survival and progression-free survival, with statistically significant advantages under certain conditions.
